Wednesday, 21 October 20261:25 pm ISTIndia edition

सच, सीधे आप तक

Book ad space

Just in

Health

Sun Pharma’s UNLOXCYT gets NCCN Category 2A recommendation for locally advanced skin cancer

Image: Indianpharmapost. Rights remain with the publisher.

The updated recommendation adds to the drug’s existing Category 2A designation for metastatic cutaneous squamous cell carcinoma

Read the full report on Indianpharmapost

Story file

Section
Health
Topics
Health alerts
First reported by
Indianpharmapost
Published
Wednesday, 21 October 2026, 12:00 am IST
Coverage
One outlet so far

How this page works. The Headline Update lists this report from Indianpharmapost with a short summary and a link to the original. The original reporting and photograph belong to the publisher. Spotted an error in our summary? Tell our corrections desk.

Related stories

More Health news

See all